Session IC: Natural Sciences Presentation 4 - Is CRISPR a Potential Treatment for Huntington’s Disease?
Location
Hope Hall
Start Date
4-3-2023 9:00 AM
End Date
4-3-2023 10:15 AM
Session Chair
Delaney Willette
Mentor
Prof. Susan Manahan
Description
An examination of the feasibility of using CRISPR as a therapeutic treatment for Huntington's Disease (HD). Most of the current treatments for diseases like HD involve the use of prescription medicines or therapies to help manage the symptoms associated with the disease. Thus, CRISPR could be used as a treatment for HD that goes beyond the treatment of symptoms. CRISPR could achieve this by removing the extra trinucleotide repeats located on the gene that codes for the mutated version of the disease. Through doing this the normal Huntingtin protein could be created rather than the pathogenic mutated Huntingtin associated with HD.
Session IC: Natural Sciences Presentation 4 - Is CRISPR a Potential Treatment for Huntington’s Disease?
Hope Hall
An examination of the feasibility of using CRISPR as a therapeutic treatment for Huntington's Disease (HD). Most of the current treatments for diseases like HD involve the use of prescription medicines or therapies to help manage the symptoms associated with the disease. Thus, CRISPR could be used as a treatment for HD that goes beyond the treatment of symptoms. CRISPR could achieve this by removing the extra trinucleotide repeats located on the gene that codes for the mutated version of the disease. Through doing this the normal Huntingtin protein could be created rather than the pathogenic mutated Huntingtin associated with HD.